Infectiologic differential diagnosis of chronic Lyme disease and so ...

More documents

Recommendations

Info

The arthritis occurs in 1% of the urethritis induced by Chlamydia trachomatis. Reiter’s triad (arthritis, uveitis, urethritis) occurs in 0.3% of those affected. The disease can be easily detected by means of laboratory diagnostics (cf. Tab. 14) in cases of existing urogenital infection. In this context, NAATs (nucleic acid amplification techniques) in urethral smear or in urine are available; this examination is also reliable for asymptomatic patients [140-142]. PCR also has a high sensitivity and specificity [143]. Table 14 Laboratory diagnostics for Chlamydia trachomatis - NAATs - PCR (detection of pathogen) - Serology - LTT* *diagnostic value has not been validated The diagnostic value of serology and LTT has not been validated. Moreover, whether a chronic infection with Chlamydia trachomatis (as is the case with LD) can be accompanied by seronegativity has not been clarified. Seropositivity can indeed provide evidence of a previous infection, but principally does not allow any statement with regard to a disorder as a consequence of a persistent infection with Chlamydia trachomatis. Theoretically, a persistent or reproducible pathological lymphocyte transformation test indicates a prolonged infection, but scientific data for the diagnostic value are not yet available. The significant data on the mode of transmission, symptomatology and treatment are summarized in Table 15. 24
Table 15 Chlamydia trachomatis Infection data, symptomatology, treatment Pathogen: - Chlamydia trachomatis Transmission: - sexual Symptomatology: - Arthritis (so-called reactive arthritis actually persistent infectious arthritis) - Reiter’s triad Arthritis Urethritis Uveitis Treatment - as in Chlamydophila pneumoniae (see Tab. 13, page 19) Duration of treatment - 3 months [234] or longer - Sulfasalazine [224], TNF antibodies [225] Yersinia enterocolitica infection (yersiniosis) 25
Page 1 and 2: Infectiologic differential diagnosi
Page 3 and 4: 3 Anamnistically, one has to consid
Page 5 and 6: Table 2 LD coinfections (not tick-b
Page 7 and 8: Table 5 Bartonellosis’ infection
Page 9 and 10: Table 6 Main disease manifestations
Page 11 and 12: 11 Fig. 1. Erythrocytes infected wi
Page 13 and 14: 13 Bartonellae are localized in ery
Page 15 and 16: ESR und CRP elevated Hypercalcemia
Page 18 and 19: Table 9 Antibiotic treatment of bar
Page 20 and 21: antibiosis is that the antibiotic i
Page 22 and 23: The laboratory diagnostics for Chla
Page 26 and 27: In the differential diagnosis of Ly
Page 28 and 29: Late phase: - Reactive arthritis -
Page 30 and 31: the depiction of chronic yersiniosi
Page 32 and 33: In Yersinia-PCR-positive patients,
Page 34 and 35: - Incubation period 3 weeks - Atypi
Page 36 and 37: system, of the skin and other organ
Page 38 and 39: - Ehrlichia chaffeensis [1] - Anapl
Page 40 and 41: Since seroprevalence merely express
Page 42 and 43: B. microti is the predominant patho
Page 44 and 45: epresent a major health hazard and
Page 46 and 47: The decisive diagnostic information
Page 48 and 49: Probable: IFA IgG 1:1024 and one of
Page 50 and 51: The main manifestation of the Campy
Page 52 and 53: The term “reactive arthritis” i
Page 54 and 55: In the diagnosis of a “reactive a
Page 56 and 57: Table 27 Disease manifestations of
Page 58 and 59: addition, other pathogens discussed
Page 60 and 61: [8] Schouls LM, Van De Pol I, Rijpk
Page 62 and 63: [25] Hermanowska-Szpakowicz T, Skot
Page 64 and 65: [43] Bakken JS, Krueth JK, Lund T,
Page 66 and 67: [60] Fox LM, Wingerter S, Ahmed A e
Page 68 and 69: [80] Marra CM. Neurologic complicat
Page 70 and 71: [100] Pulliainen AT, Dehio C. Barto
Page 72 and 73: [118] Bass JW, Freitas BC, Freitas
Page 74 and 75:
[137] Gaydos CA, Roblin PM, Hammers
Page 76 and 77:
[155] Cover TL, Aber RC. Yersinia e
Page 78 and 79:
multi-organ donors for the presence
Page 80 and 81:
[190] Straubinger RK, Straubinger A
Page 82 and 83:
[208] Bitnun A, Ford-Jones E, Blase
Page 84 and 85:
patients with reactive and undiffer
Page 86 and 87:
[242] Appelbaum PC, Gillespie SH, B
Page 88 and 89:
pneumoniae infection associated wit
Page 90 and 91:
[276] Thomas NH, Collins JE, Robb S
Page 92 and 93:
[294] File TM Jr, Segreti J, Dunbar
Page 94 and 95:
[310] Sorvillo FJ, Lieb LE, Waterma
Page 96 and 97:
henselae Isolates Collected from Ca
Page 98 and 99:
[345] Raoult D, Levy PY, Harlé JR,
show all

Infectiologic differential diagnosis of chronic Lyme disease and so ...

Create successful ePaper yourself

Delete template?

Save as template?